Protease-activated receptor (PAR)-1 is a cellular receptor for thrombin tha
t is activated after proteolytic cleavage. The contribution of PAR-1 to inf
lammatory cell-mediated renal injury was assessed in murine crescentic glom
erulonephritis (GN). A pivotal role for thrombin in this model tvas demonst
rated by the capacity of hirudin, a selective thrombin antagonist, to atten
uate renal injury. Compared with control treatment, hirudin significantly r
educed glomerular crescent formation, T cell and macrophage infiltration, f
ibrin deposition, and elevated serum creatinine, which are prominent featur
es of GN. PAR-1-defcient (PAR-1(-/-)) mice, which have normal coagulation,
also showed significant protection from crescentic GN compared with wild-ty
pe mice. The reductions in crescent formation, inflammatory cell infiltrati
on, and serum creatinine were similar in PAR-1(-/-) and hirudin-treated mic
e, but hirudin afforded significantly greater protection from fibrin deposi
tion. Treatment of wild-type mice with a selective PAR-1-activating peptide
(TRAP) augmented histological and functional indices of GN, but TRAP treat
ment did not alter the severity of GN in PAR(-/-) mice. These results indic
ate that activation of PAR-1 by thrombin or TRAP amplifies crescentic GN. T
hus, in addition to its procoagulant role, thrombin has proinflammatory, PA
R-1-dependent effects that augment inflammatory renal injury.